DK2968484T3 - Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase - Google Patents

Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase Download PDF

Info

Publication number
DK2968484T3
DK2968484T3 DK14721664.2T DK14721664T DK2968484T3 DK 2968484 T3 DK2968484 T3 DK 2968484T3 DK 14721664 T DK14721664 T DK 14721664T DK 2968484 T3 DK2968484 T3 DK 2968484T3
Authority
DK
Denmark
Prior art keywords
product
treatment method
uterine fibroids
use purified
purified collagenase
Prior art date
Application number
DK14721664.2T
Other languages
English (en)
Inventor
Phyllis Carolyn Leppert
Thomas L Wegman
Original Assignee
Biospecifics Tech Corporation
Univ Duke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biospecifics Tech Corporation, Univ Duke filed Critical Biospecifics Tech Corporation
Application granted granted Critical
Publication of DK2968484T3 publication Critical patent/DK2968484T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24003—Microbial collagenase (3.4.24.3)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DK14721664.2T 2013-03-15 2014-03-14 Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase DK2968484T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361790070P 2013-03-15 2013-03-15
PCT/US2014/029448 WO2014144859A1 (en) 2013-03-15 2014-03-14 Treatment method and product for uterine fibroids using purified collagenase

Publications (1)

Publication Number Publication Date
DK2968484T3 true DK2968484T3 (da) 2021-02-22

Family

ID=50639993

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14721664.2T DK2968484T3 (da) 2013-03-15 2014-03-14 Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase

Country Status (8)

Country Link
US (9) US9744138B2 (da)
EP (4) EP3834840B8 (da)
JP (6) JP2016515521A (da)
AU (3) AU2014228477B2 (da)
CA (2) CA2907255C (da)
DK (1) DK2968484T3 (da)
ES (2) ES3051912T3 (da)
WO (1) WO2014144859A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2802652T (pt) 2012-01-12 2019-09-10 Endo Global Ventures Enzimas de clostridium histolyticum
US20160000890A1 (en) * 2013-03-15 2016-01-07 Biospecifics Technologies Corp. Thermosensitive hydrogel collagenase formulations
EP3834840B8 (en) 2013-03-15 2025-09-17 Endo Biologics Limited Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
WO2016054197A1 (en) * 2014-09-30 2016-04-07 University Of Tennessee Research Foundation In situ gelling form for long-acting drug delivery
US10238722B2 (en) 2014-11-24 2019-03-26 Ramot At Tel-Aviv University Ltd. Pigment epithelium derived factor (PEDF) for the treatment of uterine fibroids
EP4591945A3 (en) 2017-03-01 2026-04-15 Endo Operations Limited Apparatus and method for assessing and treating cellulite
JP7227918B2 (ja) 2017-03-28 2023-02-22 エンド ベンチャーズ リミテッド コラゲナーゼ産生の改良された方法
WO2020021330A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
WO2020021332A2 (en) 2018-07-12 2020-01-30 Endo Global Aesthetics Limited Injection techniques for the treatment of cellulite
US11419610B2 (en) 2018-08-17 2022-08-23 Empress Medical, Inc. Device and method for passing tension member around tissue mass
WO2020036981A1 (en) 2018-08-17 2020-02-20 Empress Medical, Inc. Devices and methods for compressing tumors
US12239322B2 (en) 2018-08-17 2025-03-04 Empress Medical, Inc. Device and method for passing tension member around tissue mass
US20240277595A1 (en) 2018-09-18 2024-08-22 Endo Global Aesthetics Limited Compositions and methods for treating cellulite
US20220305094A1 (en) 2019-01-06 2022-09-29 Endo Global Aesthetics Limited Collagenase formulations and methods of producing the same
US11872267B2 (en) 2019-10-15 2024-01-16 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase
WO2026028155A1 (en) 2024-08-01 2026-02-05 Endo Biologics Limited Methods of treating plantar fasciitis

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821364A (en) 1966-07-08 1974-06-28 Advance Biofactures Corp Process of producing collagenase
US4524065A (en) 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US5252461A (en) 1990-05-01 1993-10-12 The Regents Of The Univ. Of California Mixed immunoglobulins for detection of rheumatoid factors
CA2047306A1 (en) 1990-07-23 1992-01-24 Milan Holjevac Mutant bacterium clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
US5256140A (en) 1992-03-27 1993-10-26 Fallien Cosmeceuticals, Ltd. Composition for levelling skin
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US6086872A (en) 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
US20020036328A1 (en) 1998-11-16 2002-03-28 William R. Richards, Jr. Offset drain fermi-threshold field effect transistors
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
RU2180002C2 (ru) 1999-08-16 2002-02-27 Пермское научно-производственное объединение "Биомед" Способ получения коллагеназы
WO2001078687A1 (en) 2000-04-18 2001-10-25 Peptron Inc. Injectable sustained release pharmaceutical composition and processes for preparing the same
JP2004528278A (ja) 2000-12-18 2004-09-16 ボード オブ レジェンツ，ザ ユニバーシティー オブ テキサス システム インサイチュヒドロゲルを用いた、局所領域の化学療法および放射線治療
US20030022856A1 (en) 2001-01-30 2003-01-30 The Regents Of The University Of Michigan Method for sustained release local delivery of drugs for ablation of unwanted tissue
US6565530B2 (en) 2001-02-28 2003-05-20 Scimed Life Systems, Inc. Immobilizing objects in the body
GB0124124D0 (en) 2001-10-08 2001-11-28 Medical Res Council Methods of treatment
US20030100830A1 (en) 2001-11-27 2003-05-29 Sheng-Ping Zhong Implantable or insertable medical devices visible under magnetic resonance imaging
AU2002331367A1 (en) 2002-07-31 2004-03-11 Pirelli And C. S.P.A. Multi-stage raman amplifier
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US20060251581A1 (en) * 2005-05-09 2006-11-09 Mcintyre Jon T Method for treatment of uterine fibroid tumors
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
JP4778053B2 (ja) * 2005-07-14 2011-09-21 リセラ，インコーポレイテッド 局所的脂肪組織処置のための徐放性増強脂肪分解処方物
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US9987221B2 (en) 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
ES2388219T3 (es) 2008-06-02 2012-10-10 F. Hoffmann-La Roche Ag Purificación mejorada de colagenasas a partir de un cultivo líquido de Clostridium histolyticum
US8236356B2 (en) 2008-06-11 2012-08-07 Roche Diagnostics Operations, Inc. Growth medium for Clostridium histolyticum
JP5421366B2 (ja) 2008-07-21 2014-02-19 オトノミ―，インク． 制御放出性の耳の構造体調節および生来の免疫システム調節化合物および耳の障害の処置のための方法
US9132199B2 (en) 2010-03-05 2015-09-15 University of Pittsburgh—of the Commonwealth System of Higher Education Reverse thermal gels and uses therefor
US20130195828A1 (en) * 2010-04-14 2013-08-01 Northwestern University Pharmaceutical Compositions and Methods for Digesting Atherosclerotic Plaques
US20130217789A1 (en) 2010-09-03 2013-08-22 North Carolina Central University Biodegradable liquogel and ph sensitive nanocarriers
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
TWI461214B (zh) 2011-06-13 2014-11-21 Univ Chang Gung Biodegradable water-sensitive glue, a drug delivery system as a carrier thereof, and a pharmaceutical composition for the treatment and / or prevention of eye diseases
JP2014530873A (ja) 2011-10-21 2014-11-20 オーキシリウム インターナショナル ホールディングス，インコーポレイテッド Ｅｆｐの治療または低減方法
EP3834840B8 (en) * 2013-03-15 2025-09-17 Endo Biologics Limited Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
KR101623856B1 (ko) 2014-10-17 2016-05-24 현대자동차주식회사 에이브이엔 장치, 차량, 및 에이브이엔 장치의 제어방법

Also Published As

Publication number Publication date
EP3834840B8 (en) 2025-09-17
US20200078310A1 (en) 2020-03-12
ES2855423T3 (es) 2021-09-23
EP3034091A1 (en) 2016-06-22
AU2014228477A1 (en) 2015-10-01
EP2968484A1 (en) 2016-01-20
JP2023159104A (ja) 2023-10-31
AU2024216497A1 (en) 2024-09-19
US10369110B2 (en) 2019-08-06
US20250339375A1 (en) 2025-11-06
JP2021107427A (ja) 2021-07-29
US20210220284A1 (en) 2021-07-22
WO2014144859A1 (en) 2014-09-18
JP2019135246A (ja) 2019-08-15
US20210023014A1 (en) 2021-01-28
CA2907255C (en) 2021-09-21
EP3834840B1 (en) 2025-08-06
US20140287032A1 (en) 2014-09-25
AU2022202925B2 (en) 2024-06-13
JP2016515521A (ja) 2016-05-30
US20140271612A1 (en) 2014-09-18
CA2907255A1 (en) 2014-09-18
EP2968484B1 (en) 2020-11-25
EP3834840A1 (en) 2021-06-16
EP4659818A2 (en) 2025-12-10
AU2022202925A1 (en) 2022-05-26
US9744138B2 (en) 2017-08-29
JP2025143277A (ja) 2025-10-01
US20170333356A1 (en) 2017-11-23
ES3051912T3 (en) 2025-12-30
JP2016135760A (ja) 2016-07-28
US20240082164A1 (en) 2024-03-14
US20260034067A1 (en) 2026-02-05
CA3208693A1 (en) 2017-03-23
EP4659818A3 (en) 2026-03-04
US11857685B2 (en) 2024-01-02
AU2014228477B2 (en) 2019-05-23

Similar Documents

Publication Publication Date Title
DK2968484T3 (da) Behandlingsfremgangsmåde og produkt til uterus fibromer, som anvender oprenset kollagenase
IL280974B (en) Systems, methods and devices for multiple coagulation point ultrasound treatment
IL267681B (en) Selective grp94 inhibitors and uses thereof
IL259530A (en) Shape changing drug delivery devices and methods
IL257580B (en) Purge device, purge stocker, and purge method
DK3057628T3 (da) Injektionsindretning til terapeutisk middel
DK3235342T3 (da) Belysningsindretning, belysningssystem og anvendelse deraf
DK3273358T3 (da) System og fremgangsmåde til udvidet pcie-strukturer (pci express)
IL246992B (en) Purge device and purge method
DK3139979T3 (da) Enhed, forstøver og fremgangsmåde
DK2968114T3 (da) Fremgangsmåde og anordning til differentiering af orale poseprodukter
DK2699397T3 (da) Apparater, system og fremgangsmåder til at danne pressede artikler og pressede artikler dannet derved
PL2967611T3 (pl) Urządzenie do usuwania ostrych blokad z naczyń krwionośnych
BR112015007494A2 (pt) aparelho para tratamento dentário.
DK2779851T3 (da) Aerosolgenererende indretning og system
DK3039146T3 (da) Produkter og fremgangsmåder til behandling af amyotrofisk lateral sklerose
DK3015670T3 (da) System til selektiv katalytisk reduktion og katalytisk regenerering
PL3838208T3 (pl) Sposoby i urządzenia do termicznej waporyzacji i kompresji tkanek
DK3008852T3 (da) System og fremgangsmåde til kryptering
DK3079719T3 (da) ANTI-SIGLEC-8-antistoffer og fremgangsmåder til anvendelse deraf
DK3233181T3 (da) Apparat til forbedret sårheling
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf
DK2964374T3 (da) Synteseanordning og fremgangsmåde
EP2967709A4 (en) THERAPEUTIC CRYOABLATION SYSTEM
BR112015019224A2 (pt) aparelho, e método